Patent ductus arteriosus: lack of evidence for common treatments.
about
Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapyChest shielding for prevention of a haemodynamically symptomatic patent ductus arteriosus in preterm infants receiving phototherapyEvidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitRole of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practiceThe definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatmentPatent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.Treatment of patent ductus arteriosus with bidirectional flow in neonates.The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after studyLung function in very preterm infants with patent ductus arteriosus under conservative management: an observational studyPatent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Outcomes of Early Ligation of Patent Ductus Arteriosus in Preterms, Multicenter Experience.Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosusShort- and Long-Term Outcomes for Extremely Preterm Infants.Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications.The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaPatent ductus arteriosus therapy: impact on neonatal and 18-month outcome.Serial echocardiography in very preterm infants: a pilot randomized trialPatent ductus arteriosus in preterm infants: do we have the right answers?Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?The timing of surgical ligation for patent ductus arteriosus is associated with neonatal morbidity in extremely preterm infants born at 23-25 weeks of gestation.Patent ductus arteriosus in the preterm infant: to treat or not to treat?Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus.Patent ductus arteriosus in preterm infants.Improved closure of patent ductus arteriosus with high doses of ibuprofen.Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.Preterm patent ductus arteriosus: should we treat it?Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre.Paracetamol to induce ductus arteriosus closure: is it valid?Managing the patent ductus arteriosus: current treatment options.Acetaminophen for patent ductus arteriosus.Echocardiographic assessment of patent ductus arteriosus in very low birthweight infants over time: prospective observational study.Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.Milrinone use for hemodynamic instability in patent ductus arteriosus ligation.Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants.Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
P2860
Q24187993-C128A5CA-3C77-4D8B-B1A7-EA2E508DB196Q24200802-0FA1F598-D5AA-42E5-A370-7994521B5CDFQ24604121-BA912A37-C006-46B7-BB34-84EF2FD05257Q24631088-4E2449AA-CA42-4DF5-A36E-2B4323C30DE0Q34018364-97F564DF-BCD0-441A-967C-928D569AC115Q34079478-69329839-1B48-44B4-8F20-947D30CCD86DQ34726703-F8EE3757-59AF-4BE7-ACF0-E65333FBD669Q34847610-50192CA0-41B5-422A-AA64-A3219F486DACQ35626826-84C85F30-0BB4-44A3-8B64-67B7A4422504Q35819433-FBCC863F-5E19-468F-AC1A-9532FCC369B6Q35834962-B3031B4C-40DF-40A6-B56C-A4A26CB55CF5Q35857832-AA0D0B9E-092A-4F54-8827-DFD5F3D8AECEQ36328450-37B9740F-7C6D-42F4-9C13-FF84909ADA05Q36599103-995BD2BA-AAFE-47CF-9F2E-1D0BA27667A8Q36714131-39AEF15C-8469-4E7A-8D71-BF55BADAB76CQ36768333-BF3BA6C2-8711-4E67-AD03-8085D9C2DCB4Q37364820-FC478DB9-03A8-425C-B700-400C4B1D7D91Q37401617-3F64331F-1915-4D8D-A0A3-5CBDA894B62FQ37451050-6A774AA8-40E2-4360-AC63-2864335ADDD3Q37482391-769215EB-5E86-48DF-9650-8FAB7DA3AC32Q37698200-E8D20308-9B45-4850-9AD9-99E54C7F0BCAQ37710387-DC497B20-99F0-404C-8693-007B1E7C053BQ37793846-2E5A31C6-AF2F-4F7D-90A4-A9DBB8D5D77EQ37831102-5BD2B36E-35FD-4F91-87B9-D5A4B1C9B884Q37870606-D97FC8C4-58C1-4262-BCC0-63A22211E9B9Q37981592-179003D2-BC00-47FB-B2A4-2641F4A97EDAQ37998378-CF89B43A-C2CA-4743-BDBE-F7EE85EE3038Q38042655-5C5D489D-A930-4AD0-AF06-085B449275DBQ38094688-BF829915-14F5-48BE-9A2D-A6AC30EF3BA3Q38100781-7A7D5290-B5E2-4CA8-AF4E-25B61B25FA9EQ38218037-EED34F98-3462-42EB-AD93-12810760C779Q38263422-5A079341-263E-4BB2-B330-855A2FFB6386Q38407110-EB9105BA-73B4-4AFF-84EC-36649350C727Q38676679-11D4A072-6C45-4733-98BD-154779D4B76EQ38806805-30E224C7-8DE2-4C33-9EC3-29B4B0FF43B8Q38930089-F283A703-1DC9-48AF-AB8F-5B6BC8097DF2Q38997232-DC8F76B9-8CC7-4A2C-B43B-6AEAED02E1D2Q39416886-4A7F2BDE-17A3-4142-AC89-6A250A767C26Q40398107-38E9F21D-3F80-4705-8365-37CF02AB0750Q41371050-08D9C85C-6547-4415-ADD9-81DC8BB89352
P2860
Patent ductus arteriosus: lack of evidence for common treatments.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Patent ductus arteriosus: lack of evidence for common treatments.
@en
type
label
Patent ductus arteriosus: lack of evidence for common treatments.
@en
prefLabel
Patent ductus arteriosus: lack of evidence for common treatments.
@en
P2860
P356
P1476
Patent ductus arteriosus: lack of evidence for common treatments.
@en
P2093
Carl L Bose
Matthew M Laughon
P2860
P304
P356
10.1136/ADC.2005.092734
P577
2007-11-01T00:00:00Z